Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Shikata-cho, Okayama, Japan.
J Dermatol. 2011 Jun;38(6):524-30. doi: 10.1111/j.1346-8138.2010.01049.x. Epub 2010 Oct 6.
In 2008, a revised World Health Organization (WHO) system of hematological neoplasm classification was promulgated. Between January 1995 and December 2008, 133 new patients with cutaneous lymphomas were seen at the dermatology clinic of Okayama University Hospital. All patients were re-classified according to the revised WHO system. The incidence rates were analyzed and the survival was estimated. Of 133 patients, 106 (79.7%) had primary cutaneous lymphomas (PCLs) and 27 (20.3%) were skin invasion from extracutaneous origin of systemic lymphoma. Compared with several reports from western countries, "mature T-cell and NK-cell neoplasms" was frequent in this study (87% vs. 77 or 72%) because of the occurrence of adult T-cell leukemia/lymphoma (ATLL) and "extranodal NK/T cell lymphoma, nasal type", with less frequent occurrence of "mature B-cell neoplasms" (13% vs. 23 or 28%). Estimated survival of patients with mycosis fungoides was favorable (5-year survival rate 90.6%), but that of the patients with primary cutaneous anaplastic large cell lymphoma (C-ALCL) was extremely less favorable than previously reported (5-year survival rate of 47.4%).
2008 年,世界卫生组织(WHO)修订了血液病肿瘤分类系统。1995 年 1 月至 2008 年 12 月期间,冈山大学医院皮肤科诊所共诊治了 133 例新发皮肤淋巴瘤患者。所有患者均按照修订后的 WHO 系统进行重新分类。分析了发病率并对生存情况进行了估计。在 133 例患者中,106 例(79.7%)为原发性皮肤淋巴瘤(PCL),27 例(20.3%)为系统性淋巴瘤皮肤侵犯。与来自西方国家的几项报告相比,由于成人 T 细胞白血病/淋巴瘤(ATLL)和“结外 NK/T 细胞淋巴瘤,鼻型”的发生,本研究中“成熟 T 细胞和 NK 细胞肿瘤”更为常见(87%比 77%或 72%),而“成熟 B 细胞肿瘤”的发生率较低(13%比 23%或 28%)。蕈样真菌病患者的生存估计情况良好(5 年生存率为 90.6%),但原发性皮肤间变性大细胞淋巴瘤(C-ALCL)患者的生存情况比之前报道的差得多(5 年生存率为 47.4%)。